Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects

letter OA: gold CC0 ⤵ 5 in-corpus citations

Abstract

Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al.,1 for endometriosis-associated pain.

My notes (saved in your browser only)

Outcome instruments

EHP-30 NRS-pain COS-Endo-2020

Condition tags

endometriosisdysmenorrheadyspareuniainfertility

MeSH descriptors

Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (5)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-06-11T06:19:26.824110+00:00
License: CC0 · commercial use OK